Terms: = Skin cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
7 results:
1. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Wolf CL; Pruett C; Lighter D; Jorcyk CL
Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
[TBL] [Abstract] [Full Text] [Related]
2. Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.
Jacobs C; Hutton B; Mazzarello S; Smith S; Joy A; Amir E; Ibrahim MF; Gregario N; Daigle K; Eggert L; Clemons M
Support Care Cancer; 2015 Nov; 23(11):3269-75. PubMed ID: 25933700
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy.
Gomez-Iturriaga A; Crook J; Evans W; Saibishkumar EP; Jezioranski J
Brachytherapy; 2011; 10(6):491-7. PubMed ID: 21345742
[TBL] [Abstract] [Full Text] [Related]
4. Negative-pressure wound therapy for musculoskeletal tumor surgery.
Sakellariou VI; Mavrogenis AF; Papagelopoulos PJ
Adv Skin Wound Care; 2011 Jan; 24(1):25-30. PubMed ID: 21173588
[TBL] [Abstract] [Full Text] [Related]
5. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract] [Full Text] [Related]
6. Effects of oncostatin M and tamoxifen on human melanoma cells.
Gibbs P; Chen Q; Robinson WA
Melanoma Res; 1998 Jun; 8(3):221-6. PubMed ID: 9664143
[TBL] [Abstract] [Full Text] [Related]
7. Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of oncostatin M in plasmacytoma development.
Barton BE; Jackson JV; Lee F; Wagner J
Cytokine; 1994 Mar; 6(2):147-53. PubMed ID: 8031997
[TBL] [Abstract] [Full Text] [Related]
